We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current SANA market cap is 1.92B. The company's latest EPS is USD -1.2849 and P/E is -6.79.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -86.19M | -81.79M | -84.05M | -116.29M | -2.18M |
| Net Income | -85.12M | -80.44M | -82.12M | -114M | 984k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -141.15M | -286.15M | -367.98M | -272.56M | -293.14M |
| Net Income | -130.78M | -285.31M | -367M | -269.48M | -283.26M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 898.1M | 822.72M | 746.93M | 707.15M | 631.44M |
| Total Liabilities | 332.08M | 323.41M | 318.67M | 352.12M | 265.59M |
| Total Equity | 566.02M | 499.32M | 428.26M | 355.03M | 365.85M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 415.7M | 730.3M | 1.13B | 822.72M | 565.3M |
| Total Liabilities | 140.88M | 298.58M | 400.91M | 323.41M | 277.79M |
| Total Equity | -142.54M | -421.18M | 728.5M | 499.32M | 287.51M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -201.37M | -290.05M | -79.27M | -138.07M | -201.62M |
| Investing | 122.13M | 210.56M | 62.73M | 105.35M | 156.7M |
| Financing | 3.85M | 4.91M | 236k | 29.74M | 29.93M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -85.5M | -137.98M | -251.05M | -290.05M | -253.58M |
| Investing | -87.86M | -252.56M | -245.8M | 210.56M | 172.01M |
| Financing | 223.73M | 435.69M | 631.75M | 4.91M | 31.65M |
| Market Cap | 1.92B |
| Price to Earnings Ratio | -6.79 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 14.4 |
| Price to Book Ratio | 6.69 |
| Dividend Yield | - |
| Shares Outstanding | 220.45M |
| Average Volume (1 week) | 2.05M |
| Average Volume (1 Month) | 1.49M |
| 52 Week Change | 65.78% |
| 52 Week High | 12.00 |
| 52 Week Low | 2.745 |
| Spread (Intraday) | 0.75 (8.22%) |
| Company Name | Sana Biotechnology Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.sana.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
